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Background/aim: The aim of this study was to investigate the medium- to long-term effects of radiofrequency (RF) ablation of genicular
nerves for chronic refractory knee pain due to osteoarthritis (OA).
Materials and methods: Forty-eight patients who underwent RF ablation of the genicular nerves were evaluated retrospectively. The
visual analogue scale (VAS) score, Western Ontario and McMaster universities osteoarthritis index (WOMAC index), opioid and
nonsteroidal antiinflammatory drug (NSAID) use score, quality of life score, and treatment satisfaction score were examined at 1, 3, and
6 months after the procedure.
Results: The mean VAS scores were significantly lower at the 1-, 3-, and 6-month evaluations compared with the preoperative values (P
< 0.001). A significant decrease was observed in the WOMAC index compared with preoperative values (P < 0.001). It was found that
66.7% of opioid users and 56.3% of NSAID users stopped using medication. No serious complications were encountered during or after
the procedure.
Conclusion: In chronic refractory knee pain due to OA, the application of RF ablation to the genicular nerve is an effective and safe
treatment option in the medium to long term.
Key words: Knee osteoarthritis, pain, genicular nerves, radiofrequency ablation

1. Introduction
Osteoarthritis (OA) is a noninflammatory chronic
degenerative disease characterized by progressive cartilage
damage, osteophyte formation, and subchondral sclerosis.
Knee OA is one of the most common joint diseases
occurring in adults, and with increases in mean duration
of life and obesity, it has become an important health
problem all over the world [1,2]. The most important
risk factor is age, and the prevalence of OA is as high as
40% in the population aged 70–75 years [3]. In elderly
populations in particular, it is among the leading causes of
pain, physical disability, and functional limitations.
As there is no curative treatment for OA, the current
treatment approach is to increase quality of life via patient
exercise training and pain control, decreasing physical and
functional impairment and disability, and preventing the
progression of the disease. Various treatment modalities that
are conservative or surgical are employed [4]. Conservative

treatment modalities include pharmacological methods
(topical agents, simple analgesics, opioids, antidepressants,
etc.), nonpharmacological approaches (training, exercise,
physiotherapy, orthesis, acupuncture, etc.), or minimally
invasive approaches like corticosteroid, viscosupplement,
or platelet-rich plasma (PRP) injections to the intraarticular region. However, these modalities fail to treat
advanced OA or stop its progression. In mild-to-moderate
OA several surgical techniques have been established;
in addition to conventional arthroscopic procedures,
there are effective and safe surgical options. High tibial
osteotomy (HTO) techniques, such as medial opening
wedge HTO [5] and arthroscopic “L” medial release [6], are
well-accepted procedures. Total knee arthroplasty (TKA)
offers satisfactory outcomes in the treatment of chronic
refractory knee pain and loss of function caused by severe
knee OA. However, survival and complications are a source
of concern. Despite satisfactory results, the application of
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this corrective surgery has been extremely low in many
parts of the world. This is the result of available information
and sociocultural factors; expectations regarding TKA
also influence patient decisions regarding this procedure.
In a recent study, Al-Mohrej et al. [7] set out to measure
knowledge and attitudes related to TKA among the Saudi
population and reported that there is still misinformation
among the public concerning TKA, its indications, and
its outcomes in Saudi Arabia. As emphasized by this
study, efforts to address misinformation could lead to
better patient–doctor interactions and increase patient
satisfaction. This will allow more patients to benefit from
this important and effective surgical treatment approach.
In some patients, treatment cannot be continued due
to side effects, while in others, despite the treatments
administered, adequate and efficient pain control cannot be
obtained [8]. In patients with OA-associated chronic knee
pain that does not respond to conservative treatments, and
among patients who do not want to undergo operations
or find surgery is counter-indicated due to accompanying
pathologies, the application of radiofrequency (RF) ablation
to the intra-articular and periarticular regions is a novel
and effective treatment option reported in the literature.
Among recent studies, some report the application of this
technique to the genicular nerves [9–19].
The knee joint is innervated by joint branches, termed
genicular nerves, which originate from distal parts of
the femoral, sciatic, and obturator nerves [20]. It is
evident that many studies are needed to determine the
efficacy and reliability of RF ablation methods applied
to the genicular nerves, and development of procedural
protocols and algorithms for users is also needed. The
aim of the present study was to retrospectively evaluate
the effect of conventional RF application on the genicular
nerves for medium- to long-term pain control, functional
improvement, and patient satisfaction in the treatment of
chronic refractory knee pain associated with OA.
2. Materials and methods
2.1. Patient selection
The present study was carried out in our department after
approval was obtained from the local ethics committee.
In the present study, data from 50 patients who were
diagnosed with OA between January 2016 and January
2017 were evaluated retrospectively through the review of
patient file records obtained via telephone or face-to-face
interview. The patients were diagnosed using the criteria
of the American College of Rheumatology (ACR). They
had stage III or IV knee OA, as determined by physical
examination and the Kellgren–Lawrence (KL) radiological
scale. Moreover, because they had chronic refractory knee
pain that did not respond to conservative treatments, the
patients underwent diagnostic genicular nerve block,

which resulted in a more than 50% decrease in pain;
subsequently, the patients underwent conventional RF
ablation in the genicular nerves.
Patients with the following characteristics were
excluded from the study: those with metabolic diseases
like chronic rheumatism, inflammatory diseases like gout,
advanced cardiac/renal disease, liver disease, uncontrolled
diabetes, dementia, or psychiatric disorders; those who
used antiplatelets/anticoagulants or had a coagulation
disorder; and finally, those who had undergone intraarticular intervention in the last 3 months with infection
at the site of intervention. In addition, one patient was
excluded due to inadequate file records and another
because an emergency cardiac operation was necessary
during the follow-up period. Overall, 48 patients who
fulfilled the criteria were included in the study.
2.2. Application of the diagnostic block to the genicular
nerves
The application of the diagnostic block to the genicular
nerves was performed by the same physician under
operating theater conditions and standard monitoring
(electrocardiogram [ECG], pulse oximeter, and
noninvasive arterial pressure) as well as superficial
sedoanalgesia accompanied by fluoroscopic imaging as an
outpatient intervention. The details of the procedure are
described below.
The anatomical topography of the genicular nerves is
shown in Figure 1. In the supine position with the knee at
30–40° flexion and supporting the region under the knee,
the region was cleaned in accordance with the asepsis/
antisepsis rules. A fluoroscope with a C arm was brought
to the anteroposterior position, and the tibiofemoral

Figure 1. Innervation of the anterior knee joint [29].
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joints were visualized. Subsequently, the probable
positions of the superior-medial, superior-lateral, and
inferior-medial genicular nerves were identified with
anteroposterior images. Skin anaesthesia was provided
under sterile conditions with a 25G needle and 0.5 cc of
1% lidocaine. Subsequently, each nerve was reached using
22G Whitacre spinal needles. The needles were advanced
while maintaining bone contact; after their positions were
corroborated in images of fluoroscopy (intersection point
of 2/3 anterior and 1/3 posterior of the femur and tibia),
each genicular nerve was blocked with 1 cc of 2% lidocaine.
2.3. Application of conventional RF ablation to the
genicular nerves
Patients whose pain decreased by over 50% after diagnostic
block underwent conventional RF application. The steps
described in the diagnostic block were followed in a similar
manner until the administration of local anaesthesia.
Following local anaesthesia, 22G RF needles with active
tips (100 mm) were inserted from predetermined entrance
points to produce a lesion in the nerve. The needles were
advanced while maintaining contact with the bone, and
the positions of the needles were confirmed with lateral
fluoroscopy images at the intersection point of 2/3 anterior
and 1/3 posterior of the femur and tibia. Then, an electrode
placed in an RF needle was connected to an RF generator
(Neurotherm NT1100) and motor (0.5V), and sensorial
(50 Hz) stimulations were applied to each genicular nerve
to ensure the correct position of the needle. After ensuring
that the motor stimulus was not received until about 2V,
the RF denervation procedure was initiated. Before RF
application, 2 mL of 2% lidocaine was administered to

each nerve, and then conventional RF was applied at 80 °C
for 60 s. The electrode position is shown in Figure 2.
2.4. Evaluation of the patients
The demographic information of all the patients, as well
as their clinical characteristics before the procedure and
KL radiological staging, were recorded. The primary
aim of the study was to determine the decrease in pain
severity in the medium and long term; the secondary aim
was determining the increase in medium- to long-term
quality of life and patient satisfaction. For this purpose, the
variables described below were used for patient evaluation
at 1, 3, and 6 months and in the follow up.
Severity of pain was evaluated with a 10 cm visual
analogue scale (VAS). A VAS score <4 was considered
to represent adequate analgesia. The physical functions
of the knee were evaluated using the Turkish-validated
form of Western Ontario and McMaster universities
osteoarthritis (WOMAC) index [21]. For pain, stiffness,
and physical functions, WOMAC-P, WOMAC-S, and
WOMAC-PF index scores, respectively, and total
WOMAC (WOMAC-T) scores obtained from the sum of
these 3 parts, were recorded. For patients who were using
nonsteroidal antiinflammatory drugs (NSAIDs) and/or
opioids prior to the procedure, we determined whether the
treatment had any effect on drug use by using a 3-point
scale (1: similar, 2: decreased, 3: discontinued). To evaluate
the effects of the treatment on quality of life, the following
question was asked: “How did your quality of life change?”
In response, the patients were instructed to choose one of
four options: better, good, similar, or bad. At the end of the
study, the patients were asked if they were satisfied with

Figure 2. A: Anterior/posterior and B: lateral fluoroscopic images of the final electrode positions during
conventional RF ablation of the genicular nerves.
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the treatment, and the responses were scored as follows: 1:
bad, 2: moderate, 3: good, and 4: perfect.
2.5. Statistical analysis
A G-Power program analysis concluded before the study
calculated that, with an error margin of 0.05, statistical
power of 0.95, and effect size of 0.5, at least 30 patients
needed to be included in the study. To allow for missing
follow-up forms, 50 patients were enrolled in the study.
Data analysis was conducted using the SPSS 15.0
program (SPSS Inc., Chicago, IL, USA). The descriptive
statistics were expressed as the mean, standard deviation,
median, minimum, and maximum for continuous
variables and the number of cases and percentage (%)
for categorical variables. The Shapiro–Wilk test was used
to evaluate whether continuous variables were normally
distributed.
The Friedman test for data that were nonlinearly
distributed was used to determine whether there were
statistically significant differences between the VAS,
WOMAC, and quality scores at different follow-up times.
When the result of the Friedman test was significant, the
Wilcoxon signed-rank test was employed to determine
the follow-up timepoint(s) that created the difference.
When the data were linearly distributed, the follow-up
timepoint creating the difference was detected with the
paired-samples t-test. Whether there was significant
difference in the use of opioids and NSAIDs at 1, 3, and 6
months compared with the baseline was investigated using
Pearson’s chi-square test. Correlation between the VAS
scores and WOMAC, satisfaction, and quality of life scores
was investigated with Spearman correlation tests in data
that were not linearly distributed; P <0.05 was considered
significant for all results.
3. Results
The demographic and clinical characteristics of the 48
patients (29 female [60.4%], 19 male [39.6%]) included in
the study are listed in Table 1. The mean VAS scores of
the patients included in the present study at different time
points are shown in Table 2. VAS values were ˂4 in all the
patients except for one patient at the end of the first month
and three patients at the end of 6 months. Compared with
the VAS scores recorded before the procedure, the mean
VAS scores at 1, 3, and 6 months after the procedure were
significantly lower (P < 0.001; Figure 3).
Posttreatment opioid use scores of patients who were
using opioids prior to the procedure are listed in Figure 4.
Prior to treatment, 18 patients (37.5%) were taking opioid
analgesic drugs. At 1, 3, and 6 months after treatment,
61.1%, 27.8%, and 33.3% of the patients, respectively, had
decreased their opioid use, and 38.9%, 72.2%, and 66.7%
discontinued opioid use, with statistically significant
changes (P < 0.001; Figure 4).

Table 1. Demographic and clinical characteristics of the patients.
Variables
Age (year)

77.2 ± 5.2

Sex
Female
Male

29 (60.4%)
19 (39.6)

Weight (kg)

77.1 ± 5.1

Side
Single knee
Both knees

42 (87.5%)
6 (12.5%)

Duration of pain (year)

4.7 ± 1.8

KL stage
Stage 3
Stage 4

41 (85.4%)
7 (14.6%)

Arthroscopic surgery
Yes
No

11 (22.9%)
37 (77.1%)

Baseline opioid use
Present
Absent

18 (37.5%)
30 (62.5%)

Baseline NSAI use
Present
Absent

100 (100%)
0 (0%)

Data are expressed as mean ±SD (standard deviation) and n
(number of patients).

Before the procedure, 100% of the patients were
using NSAIDs. At 1, 3, and 6 months posttreatment,
41.7%, 43.8%, and 39.6% of the patients, respectively,
decreased their NSAID use, while 50%, 52.1%, and 56.3%
discontinued NSAID use, with statistically significant
changes between the values before the procedure and after
the procedure (P < 0.001; Figure 5).
Changes in the mean WOMAC scores of the patients
are shown in Table 3. Compared with the values before
the procedure, the WOMAC-P, WOMAC-PF, and
WOMAC-S scores decreased significantly at 1, 3, and
6 months posttreatment. Similarly, the total WOMAC
scores were lower at 1, 3, and 6 months compared with
the baseline, and they were significantly lower at 3 and 6
months compared with 1 month. The greatest decrease in
the WOMAC-T score, when compared with pretreatment
values, occurred at 6 months.
Significant improvement was observed in quality
of life after treatment (Figure 6). At 1, 3, and 6 months
after treatment, 79.1%, 79.2%, and 79.1% of the patients,
respectively, reported that their quality of life was better. At
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Table 2. Mean (±SD), median, minimum, and maximum VAS scores at different follow-up
times.
n

Mean ±SD

Median

Smallest

Largest

48

7.4 ± 1.3

7

5

10

1. month

48

2.2 ± 1.0

2

0

5

3. month ±

48

1.5 ± 1.0

1.5

0

3

6. month

48

2.0 ± 1.2

2

0

5

Before the procedure
*

€

*±€

*The difference between the baseline and month 1 is statistically significant (P < 0.001).
±The difference between the baseline and month 3 is statistically significant (P < 0.001).
€ The difference between baseline and month 6 is statistically significant (P < 0.001).

Figure 3. Graphic for the change in VAS scores at different follow-up times. *Difference between baseline
and month 1 is statistically significant (P < 0.001). ±Difference between baseline and month 3 is statistically
significant (P < 0.001). €Difference between baseline and month 6 is statistically significant (P < 0.001).
¥Difference between month 1 and month 3 is statistically significant (P < 0.001). £Difference between
month 3 and month 6 is statistically significant (P < 0.001). µDifference between month 1 and month 6 is
not statistically significant (P = 0.26).

1, 3, and 6 months the quality of life scores increased as the
VAS scores decreased; however, a significant correlation
was only found between the 6 month VAS scores and
quality of life scores (coefficient of correlation = −0.41, P
= 0.003).
After treatment, patient satisfaction levels were high.
The satisfaction levels were as follows: 77.1% perfect,
14.6% good, 6.3% moderate, and 2.1% bad. After the
end of the study, 97.9% of the patients (all except one)
reported that they would undergo the procedure again.
A significant negative correlation was found between
patient satisfaction and the WOMAC-T score; that is, at all
timepoints, the patient satisfaction level increased as the
WOMAC-T score decreased.
No serious side effects or complications occurred in
association with the treatment applied. In two patients,
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hematoma and ecchymosis occurred at the needle sites;
in one patient, painless paresthesia around the knee
was evident, and this resolved spontaneously without
treatment in 1 day.
4. Discussion
The present study demonstrated that, in chronic
refractory knee pain associated with OA, the application
of conventional RF ablation decreased analgesic use
and increased quality of life and patient satisfaction.
Moreover, it resulted in effective analgesia and functional
improvement in the medium and long term without
serious side effects.
Since the first publication on pulsed RF application to
the intra-articular region [22], studies investigating the
efficacy of various RF modalities, such as conventional RF

KONYA et al. / Turk J Med Sci

Figure 4. Opioid usage scores during follow-up times. Data are as expressed as the percentage of
patients. *At month 1 compared to baseline, decrease in opioid use and its discontinuation is
statistically significant (P < 0.001). ±At month 3 compared to baseline, decrease in opioid use and
its discontinuation is statistically significant (P < 0.001). €At month 6, decrease in opioid use and its
discontinuation is statistically significant (P < 0.001).

Figure 5. NSAID usage scores during follow-up times. *At month 1 compared to baseline, decrease in NSAID
use and its discontinuation is statistically significant (P < 0.001). €At month 3 compared to baseline, decrease
in NSAID use and its discontinuation is statistically significant (P < 0.001). ±At month 6 compared to baseline,
decrease in NSAID use and its discontinuation is statistically significant (P < 0.001).

[9–16], cooled RF [17–19], and pulsed RF [23–25] applied
to the intra-articular and periarticular regions in patients
with chronic knee pain have appeared. Many such studies
have been reported in the literature in the last decade.
The application of conventional RF to genicular nerves
under fluoroscopic guidance was originally described
by Choi et al. [9] in 2011. In their randomized, doubleblind study comparing genicular nerve blockage and

conventional RF, there was over 50% relief and associated
functional improvement in knee pain for 12 weeks without
any side effects. For the procedure, a 100 mm RF needle
with active tip was used, and each nerve lesion was
produced at 70 °C for 90 s.
In the conventional RF application from the present
study a 100 mm active-tip RF needle was used, and in a
departure from Choi et al. [9], a lesion was produced
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Table 3. Mean WOMAC-P, WOMAC-S, WOMAC-PF, and WOMAC-T scores at different
follow-up times.
Before procedure

1. month

3.month

WOMAC-P

12.0 ± 2.3

4.9 ± 1.7

4.1 ± 1.2*

3.7 ± 1.2*£¥

WOMAC-S

4.4 ± 1.4

2.7 ± 0.9*

2.7 ± 0.9*

2.7 ± 0.9*

WOMAC-PF

46.1± 6.4

28.8 ± 5.8*

28.7 ± 5.5*

WOMAC-Total

62.2 ± 9.4

36.5± 7.4*

35.5 ± 6.3*

*± ¥

β#

6.month
±£

28.5 ± 5.5*
β

35.1 ± 6.4* #

Data are expressed as mean ±SD. *Statistically significant difference before the procedure and at
1, 3, and 6 months postprocedure (P < 0.01). ±Statistically significant difference between month
1 and month 3 (P < 0.001). £Statistically significant difference between month 3 and month
6 (P < 0.006). ¥Statistically significant difference between month 1 and month 6 (P < 0.001).
βStatistically significant difference between month 1 and month 3 (P < 0.05). #Statistically
significant difference between month 1 and month 6 (P < 0.001).

Figure 6. Quality of life scores during follow-up times. *Month 1 quality of life scores significantly better
(P < 0.05). ±Month 3 quality of life scores significantly better (P < 0.05). ¥Month 6 quality of life scores
significantly better (P < 0.05).

at each nerve at 80 °C for 60 s. A 75% reduction in the
median VAS scores was observed in the 1, 3, and 6 month
measurements. When follow up was terminated at 6
months, the percentage of patients with VAS scores ≤4
was found to be quite high (93.75%). In parallel to the
satisfactory analgesia obtained, analgesic consumption
decreased, while quality of life increased significantly.
Moreover, no serious side effects occurred. As the duration
of follow up was 6 months, we could not determine how
long the obtained effect lasted. However, according to
observations made in clinical practice, the clinical effect
was maintained for up to 1 year.
In the present study, the WOMAC OA index was
also used to evaluate the efficacy of treatment, and it was
compared with scores from the preprocedural period;
a significant decrease was found in total and subgroup
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WOMAC scores at all follow-up timepoints. The results of
the present study are compatible with those of many studies
using WOMAC as an indicator of improvement in quality
of life; similar to those studies, our results demonstrated
that conventional RF considerably decreased knee pain,
stiffness, and disability after 6 months of follow up
[9,13,16].
In conventional RF, the size of the lesion varies
depending on the distance to the nerve, duration of
application, target heat, and length of the active tip. In the
studies regarding conventional RF application to genicular
nerves, there is no standardization in the parameters used.
For example, the length of the active tip varies between
5 and 10 mm, the heat used in the procedure varies
between 60–80 °C, and duration of procedure varies
90–270 s. Although comparative studies have not been
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carried out, it is our view that these technical differences
may change the long-term of efficacy of conventional RF.
For instance, in studies with 3–6 months of follow up
that used 10 mm active-tip RF needles [9–12,15,16], the
improvements lasted for time periods similar to those in
the present study. Ikeuchi et al. [14] used a 5 mm activetip RF needle, and the improvements disappeared within 6
months. In contrast, in a retrospective study in which the
lesion was applied at 60 °C, which is generally preferred
in the literature, a temperature of 80 °C achieved physical
and functional improvement for 6 months, similar to the
findings in other studies [12]. In the present study the
lesion was produced at 80 °C using an RF needle with a
10 mm active tip, and unlike other studies, the duration
of the procedure was 60 s; however, adequate physical
and functional improvement was obtained. Therefore, we
suggest that randomized prospective studies comparing
the temperature used, duration of lesion production, as
well as active-tip size, are required.
In addition to the conventional RF application method,
cooled RF, and pulsed RF methods may also be utilized.
Although there has been no randomized study comparing
these methods, Gupta et al. [26] evaluated the efficiency of
the three methods in a review and reported that all three
have similar safety and efficiency profiles.
In the literature, there are also studies comparing
RF methods with conservative treatments. One study
comparing intra-articular steroid, local anaesthetic, and
opioid injections with conventional RF found conventional
RF application to the genicular nerves provided better
analgesia and improved joint functions efficiently and
reliably [16].
Radiofrequency application to genicular nerves
has traditionally been carried out under fluoroscopy;
now it is being carried out with ultrasonography (USG)
[15,22]. Ultrasonography is easier, provides more
accurate visualization of neurovascular structures, and
does not involve exposure to radiation, when compared
with fluoroscopy [22]. However, there is not adequate
evidence at present indicating the superiority of USG to
fluoroscopy; furthermore, the need for devices and the
additional training required are among its disadvantages.
In a recent anatomic study performed with cadavers, it
was demonstrated that, although the course of the nerves
was variable at the proximal area, in the distal region,
where there was contact between the femur and tibia, it

was constant [27]. Therefore, it is our opinion that the
probability of an unsuccessful block due to anatomic
variation is not high in this region, and conventional RF
application to the genicular nerves can be carried out
safely and efficiently under the guidance of fluoroscopy.
In OA-associated knee pain, conventional RF
application to the genicular nerves is regarded as a
safe intervention with low complication rates, as no
serious side effects have been reported. The results of
the present study confirm this. Apart from hematoma
and ecchymosis at the needle sites in two patients and
painless paraesthesia lasting for 1 day around the knee that
resolved spontaneously in one patient, no complications
occurred. In a study by McCormick and Walega [28], an 8
mm third-degree skin burn was reported in the injection
region following the application of conventional RF with
a 100 mm active-tip needle at 80 °C for 90 s. Investigators
have stressed that in order to prevent skin burns that
may develop in RF ablation applications, especially in
patients with a low body mass index, the length of the
electrode active tip, degree of the lesion, and duration of
the procedure should be individualized; and to avoid the
risk of electrode migration, fluoroscopic images should be
obtained at certain intervals. Although no complications
occurred in the present study, with the increasing
popularity of the procedure and emphasis in the literature
on probable complications, we suggest taking precautions
in accordance with the recommendations; furthermore,
when necessary, treatment should be individualized.
The retrospective nature of this study, lack of a control
group, and the limited 6-month follow-up duration may
be considered limitations of the present research. It is our
view that this study may provide guidance for further
prospective, controlled, and long-term studies comparing
RF applications with both placebo and other RF methods
(pulsed RF, cooled RF, etc.).
In conclusion, conventional RF ablation application
to the genicular nerves is an effective analgesia method
that decreases the consumption of NSAIDs and opioids
in the medium and long term, provides functional
improvement with satisfactory and adequate analgesia,
and increases quality of life, with high patient satisfaction
and without serious side effects in chronic refractory knee
pain associated with OA. However, further longer-term
randomized, controlled, double-blind studies with larger
patient series are required to substantiate these findings.
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